Microbio Co (ROCO:4128) Cyclically Adjusted Revenue per Share: NT$ (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4128 Microbio Co Ltd ROCO:4128
61 GF Score
Price NT$14.60
GF Value NT$37.07
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Microbio Co Cyclically Adjusted Revenue per Share?

Microbio Co ROCO:4128 -0.34% 61 Cyclically Adjusted Revenue per Share is NT$ as of Jun. 2026. GuruFocus rates ROCO:4128 with a GF Score™ of 61/100 and a GF Value™ of NT$37.07 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Microbio Co's adjusted revenue per share for the three months ended in Jun. 2026 was NT$0.815. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is NT$ for the trailing ten years ended in Jun. 2026.

During the past 12 months, Microbio Co's average Cyclically Adjusted Revenue Growth Rate was 2.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Microbio Co was 5.40% per year. The lowest was 2.20% per year. And the median was 4.30% per year.

As of today (2026-09-20), Microbio Co's current stock price is NT$14.60. Microbio Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was NT$. Microbio Co's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Microbio Co was 39.01. The lowest was 3.41. And the median was 13.25.


Microbio Co  (ROCO:4128) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Microbio Co was 39.01. The lowest was 3.41. And the median was 13.25.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Microbio Co Cyclically Adjusted Revenue per Share Related Terms


Microbio Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Microbio Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbio Co Cyclically Adjusted Revenue per Share Chart

Microbio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Microbio Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ROCO:4128 vs KHC, GIS: Cyclically Adjusted Revenue per Share Comparison

For the Packaged Foods subindustry, Microbio Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbio Co Cyclically Adjusted PS Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Microbio Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Microbio Co's Cyclically Adjusted PS Ratio falls into.


ROCO:4128
61GF Score
Microbio Co Ltd ROCO:4128
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbio Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Microbio Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.815/333.9520*333.9520
=0.815

Current CPI (Jun. 2026) = 333.9520.

Microbio Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.609 241.428 0.842
201612 0.677 241.432 0.936
201703 0.571 243.801 0.782
201706 0.577 244.955 0.787
201709 0.587 246.819 0.794
201712 0.663 246.524 0.898
201803 0.585 249.554 0.783
201806 0.604 251.989 0.800
201809 0.589 252.439 0.779
201812 0.681 251.233 0.905
201903 0.601 254.202 0.790
201906 0.608 256.143 0.793
201909 0.635 256.759 0.826
201912 0.727 256.974 0.945
202003 0.751 258.115 0.972
202006 0.719 257.797 0.931
202009 0.712 260.280 0.914
202012 0.740 260.474 0.949
202103 0.691 264.877 0.871
202106 0.856 271.696 1.052
202109 0.794 274.310 0.967
202112 0.766 278.802 0.918
202203 0.685 287.504 0.796
202206 0.750 296.311 0.845
202209 0.657 296.808 0.739
202212 0.765 296.797 0.861
202303 0.659 301.836 0.729
202306 0.624 305.109 0.683
202309 0.685 307.789 0.743
202312 0.738 306.746 0.803
202403 0.701 312.332 0.750
202406 0.692 314.175 0.736
202409 0.728 315.301 0.771
202412 0.807 315.605 0.854
202503 0.776 319.799 0.810
202506 0.770 322.561 0.797
202509 0.806 324.800 0.829
202512 0.868 324.054 0.895
202603 0.853 330.213 0.863
202606 0.815 333.952 0.815

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of NT$ mean?
Microbio Co (ROCO:4128) has a Cyclically Adjusted Revenue per Share of NT$ as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Microbio Co and its competitors.
Is Microbio Co's Cyclically Adjusted Revenue per Share too high?
Microbio Co's current Cyclically Adjusted Revenue per Share is NT$. Overall, Microbio Co has a GF Score™ of 61/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Microbio Co's Cyclically Adjusted Revenue per Share compare to KHC and GIS?
Microbio Co's Cyclically Adjusted Revenue per Share of NT$ can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted Revenue per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Microbio Co and its competitors. Microbio Co's current Cyclically Adjusted Revenue per Share is NT$. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbio Co stock overvalued right now?
Based on GuruFocus' analysis, Microbio Co (ROCO:4128) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$37.07, compared to a current price of NT$14.60 — trading 60.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is NT$. Microbio Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Microbio Co (ROCO:4128), the current Cyclically Adjusted Revenue per Share is NT$ as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbio Co (ROCO:4128) Overvalued in 2026?

Based on GuruFocus' analysis, Microbio Co stock appears to be undervalued. The current stock price of NT$14.60 is trading 60.6% below its estimated GF Value™ of NT$37.07. GuruFocus considers Microbio Co to be Significantly Undervalued.

Key valuation signals for ROCO:4128:

  • Cyclically Adjusted Revenue per Share: NT$
  • GF Value™: NT$37.07 vs. price of NT$14.60 (60.6% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the ROCO:4128 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Microbio Co Business Description

Address Yuanqu Street, No. 3, 18th Floor - 1, Sanchong Village, Nangang District, Taipei, TWN
Microbio Co Ltd is engaged in the research and development, manufacturing, and trading of biotech drugs and dietary supplements. Its drug portfolio includes MS-20, a mixture of soybean fermentation metabolites, which improves fatigue and loss of appetite in cancer patients undergoing chemotherapy. In addition, the company also offers Lee Herb series of herbal essence drinks, Tien Chun Bao oral solutions, Herbiron oral solutions for iron deficiency, and other pharmaceutical and organic products. The company generates revenue from biotech drug research and development and the sale of dietary supplements. The majority of its revenue is generated from the sale of its dietary supplements.
61GF Score

Get the complete analysis for ROCO:4128

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$14.60
Price
NT$37.07
GF Value